A new market beckons for Alzheimer’s blood tests
If drugs acting on amyloid and tau can defy the sector’s history of failure, the testing landscape will change dramatically.
If drugs acting on amyloid and tau can defy the sector’s history of failure, the testing landscape will change dramatically.
